RVPH icon

Reviva Pharmaceuticals

12 hedge funds and large institutions have $10.5M invested in Reviva Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
TCM
1
Tang Capital Management
California
$4.88M
AC
2
Armistice Capital
New York
$2.57M -$342K -84,000 -12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.07M -$83.1K -20,408 -4%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$313K +$37.6K +9,240 +14%
ECM
5
EMC Capital Management
Texas
$265K
BlackRock
6
BlackRock
New York
$136K +$61.6K +15,152 +83%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$108K +$108K +26,635 New
Bank of America
8
Bank of America
North Carolina
$101K +$101K +24,806 New
HF
9
HRT Financial
New York
$54K +$54K +13,453 New
Northern Trust
10
Northern Trust
Illinois
$43K
UBS Group
11
UBS Group
Switzerland
$6K -$1.73K -455 -22%
TRCT
12
Tower Research Capital (TRC)
New York
-$61K -12,484 Closed
Renaissance Technologies
13
Renaissance Technologies
New York
-$55K -11,250 Closed
DC
14
Davenport & Co
Virginia
-$49K -10,000 Closed